Viral vector technology for cell type specific gene delivery
Viral vector technology for cell type specific gene delivery
批准号:
10796647
负责人:
Aaron Matthew LeBeau
金额:
$14.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-03-01 至 2026-02-28
关键词:
AccelerationAdministrative SupplementAntibodiesCell SeparationCellsCore FacilityDedicationsDependovirusEngineeringFee-for-Service PlansGene DeliveryHereditary DiseaseInvestmentsMalignant NeoplasmsMeasuresMinnesotaResearchRunningSecureTechnologyTimeUniversitiesViral Vectorcell typedesignexperimental studygene therapymembernoveltechnology platformtimelinevirus tropism
中文摘要
项目摘要
此行政补充是购买索尼台式SH 800细胞分选机。细胞分选对于
我们合理设计腺相关病毒嗜性的方法(参见R 01 GM 141152“病毒载体技术
用于细胞类型特异性基因递送”)。在明尼苏达大学的Flow Core设施中,细胞分选仅可用于
作为由流程核心工作人员执行的“收费服务”。在这种限制下,我们遇到了两个问题:1)
由于Flow Core的两台分拣机的使用率很高,我们很难确保有足够的时间进行
在我们的R 01中概述的研究。2)对于许多试验/优化实验,Flow Core的高吞吐量
分类器没有得到充分利用,它们的复杂性实际上是一个障碍。台式分拣机将缩短时间
连续的AAV设计/测量/优化周期所需的时间,从而能够加速AAV设计/测量/优化周期的时间轴。
在我们的R 01中概述的实验。综上所述,需要购买一个专门用于该项目的细胞分选机,
紧急
英文摘要
Project Summary
This administrative supplement is to purchase a Sony benchtop SH800 cell sorter. Cell sorting is essential for
our approach to rationally engineer Adeno-Associated Virus tropism (see R01GM141152 ”Viral vector technology
for cell type specific gene delivery”). At the University of Minnesota Flow Core facility, cell sorting is only available
as a ‘fee-for-service’ performed by a flow core staff member. With this limitation, we have run into two issues: 1)
Because of heavy utilization of the Flow Core’s two sorters, we have trouble securing enough time to conduct
research outlined in our R01. 2) For many pilot/optimization experiments, the high throughput of the Flow Core’s
sorters is underutilized, and their complexity is actually a hindrance. A benchtop sorter will shorten the time
required for consecutive AAV design/measure/optimize cycles and thus enable an accelerated timeline of
experiment outlined in our R01. Taken together, the need to purchase a cell sorter dedicated to this project is
urgent.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Viral vector technology for cell type specific gene delivery
-
批准号:10365787
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2022
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Viral vector technology for cell type specific gene delivery
-
批准号:10581499
-
项目类别:
-
资助金额:$34.27万
-
财政年份:2022
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Targeting CD133 for imaging and therapy in prostate cancer
-
批准号:10410106
-
项目类别:
-
资助金额:$35.57万
-
财政年份:2021
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Targeting CD133 for imaging and therapy in prostate cancer
-
批准号:10653106
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2021
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Targeting CD133 for imaging and therapy in prostate cancer
-
批准号:10470959
-
项目类别:
-
资助金额:$35.57万
-
财政年份:2021
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
-
批准号:10545171
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2020
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
-
批准号:10321260
-
项目类别:
-
资助金额:$34.86万
-
财政年份:2020
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
-
批准号:10062931
-
项目类别:
-
资助金额:$16.44万
-
财政年份:2020
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Cyclic Peptide Protease Inhibitors for the Treatment of Prostate Cancer
-
批准号:10408279
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2020
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Novel Radioimmunotherapy Strategies for Prostate Cancer
-
批准号:10470949
-
项目类别:
-
资助金额:$34.24万
-
财政年份:2019
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Novel Radioimmunotherapy Strategies for Prostate Cancer
-
批准号:10650786
-
项目类别:
-
资助金额:$33.55万
-
财政年份:2019
-
负责人:Aaron Matthew LeBeau
-
依托单位:
Novel Radioimmunotherapy Strategies for Prostate Cancer
-
批准号:10411260
-
项目类别:
-
资助金额:$34.24万
-
财政年份:2019
-
负责人:Aaron Matthew LeBeau
-
依托单位:
海外基金